A modified FLOT regimen (fluorouracil, oxaliplatin, and docetaxel; TFOX) outperformed a standard chemotherapy triplet for the ...

Four specific genes serve as a telltale clue to how potentially deadly stomach cancers will develop and progress, a new study says.

Researchers using next-generation DNA sequencing have identified four specific genes whose mutations are linked to the ...

Postoperative histopathology confirmed a moderately differentiated neoplasm comprising both squamous cell carcinoma and adenocarcinoma ... ulcerative lesion in the gastric antrum, characterized by ...

Through a series of convincing and systematic experiments, the author thoroughly investigates the role of FRMD8 in breast cancer and its underlying regulatory ... reveals that the number of ...

HLX22 received orphan drug designation, offering incentives like tax credits and market exclusivity to accelerate development for gastric cancer treatment. Phase 2 trial results showed HLX22 improved ...

uniklinikum-dresden.de Objective Gastric cancer is the second leading cause of cancer-related deaths and the fifth most common malignancy worldwide. In this study, human and mouse gastric cancer ...

Background Development of diffuse-type gastric cancer (DGC) starts with intramucosal lesions that are primarily composed of differentiated ... the stepwise progression of the disease remains poorly ...

Gastric cancer is associated with a poor prognosis, particularly in advanced stages of the disease where the five-year survival rate is 5% to 10%. 1 Current recommended first-line treatment for ...

Gastric cancer is associated with a poor prognosis, particularly in advanced stages of the disease where the five-year survival rate is 5% to 10%. 1 Current recommended first-line treatment for HER2 ...